A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null mice

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Human Molecular Genetics

• Publication date

  2018-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddy185PMID 29771357
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lysosomes convene to keep the synapse clean

  2017cited by this paper
• Elevated Expression of Moesin in Muscular Dystrophies.

  2017cited by this paper
• Identification of serum protein biomarkers for utrophin based DMD therapy

  2017cited by this paper
• Halofuginone promotes satellite cell activation and survival in muscular dystrophies.

  2016cited by this paper
• Ca2+-regulated lysosome fusion mediates angiotensin II-induced lipid raft clustering in mesenteric endothelial cells

  2016cited by this paper
• A correlation between selenium and carnitine levels with hypo-osmotic swelling test for sperm membrane in low-grade varicocele patients.

  2015cited by this paper
• Exon 32 Skipping of Dysferlin Rescues Membrane Repair in Patients’ Cells

  2015cited by this paper
• Membrane Injury and Repair in the Muscular Dystrophies

  2015cited by this paper
• Membrane Repair: Mechanisms and Pathophysiology.

  2015cited by this paper
• Halofuginone — The Multifaceted Molecule

  2015cited by this paper
• Synaptotagmin-7 phosphorylation mediates GLP-1–dependent potentiation of insulin secretion from β-cells

  2015cited by this paper
• Inhibition of muscle fibrosis results in increases in both utrophin levels and the number of revertant myofibers in Duchenne muscular dystrophy

  2015cited by this paper
• Direct Transfer of Viral and Cellular Proteins from Varicella-Zoster Virus-Infected Non-Neuronal Cells to Human Axons

  2015cited by this paper
• Neuraminidase-1 mediates skeletal muscle regeneration.

  2015cited by this paper
• Synaptotagmin-7 links fusion-activated Ca2+ entry and fusion pore dilation

  2014cited by this paper
• Rapid actin‐cytoskeleton–dependent recruitment of plasma membrane–derived dysferlin at wounds is critical for muscle membrane repair

  2014cited by this paper
• Synaptotagmin 7 functions as a Ca2+-sensor for synaptic vesicle replenishment

  2014cited by this paper
• Halofuginone improves muscle-cell survival in muscular dystrophies.

  2014cited by this paper
• Dealing with damage: plasma membrane repair mechanisms.

  2014cited by this paper
• Calpain cleavage within dysferlin exon 40a releases a synaptotagmin-like module for membrane repair

  2014cited by this paper
• Myofiber-specific inhibition of TGFβ signaling protects skeletal muscle from injury and dystrophic disease in mice.

  2014cited by this paper
• Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies

  2013cited by this paper
• The hypo-osmotic swelling test for evaluation of sperm membrane integrity.

  2013cited by this paper
• Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginone.

  2013cited by this paper
• Lysosome fusion to the cell membrane is mediated by the dysferlin C2A domain in coronary arterial endothelial cells

  2012cited by this paper
• Involvement of Host Stroma Cells and Tissue Fibrosis in Pancreatic Tumor Development in Transgenic Mice

  2012cited by this paper
• TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout mice

  2012cited by this paper
• Dysferlin, Annexin A1, and Mitsugumin 53 Are Upregulated in Muscular Dystrophy and Localize to Longitudinal Tubules of the T-System With Stretch

  2011cited by this paper
• Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase

  2011cited by this paper
• Using the fluorescent styryl dye FM1-43 to visualize synaptic vesicles exocytosis and endocytosis in motor nerve terminals.

  2011cited by this paper
• Impaired muscle growth and response to insulin-like growth factor 1 in dysferlin-mediated muscular dystrophy.

  2011cited by this paper
• Halofuginone and muscular dystrophy.

  2011cited by this paper
• Control of Exocytosis by Synaptotagmins and Otoferlin in Auditory Hair Cells

  2010cited by this paper
• Fibrosis inhibition and muscle histopathology improvement in laminin‐α2‐deficient mice

  2010cited by this paper
• Proteomic Analysis of the Dysferlin Protein Complex Unveils Its Importance for Sarcolemmal Maintenance and Integrity

  2010cited by this paper
• Halofuginone inhibits Smad3 phosphorylation via the PI3K/Akt and MAPK/ERK pathways in muscle cells: effect on myotube fusion.

  2010cited by this paper
• Halofuginone Inhibits TH17 Cell Differentiation by Activating the Amino Acid Starvation Response

  2009cited by this paper
• Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies.

  2009cited by this paper
• Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function

  2009cited by this paper
• Synaptotagmin‐7 is a principal Ca2+ sensor for Ca2+‐induced glucagon exocytosis in pancreas

  2009cited by this paper
• Prevention of muscle fibrosis and improvement in muscle performance in the mdx mouse by halofuginone.

  2008cited by this paper
• Targeting TGFβ signaling to inhibit fibroblast activation as a therapy for fibrosis and cancer: effect of halofuginone

  2008cited by this paper
• Dysferlin in Membrane Trafficking and Patch Repair

  2007cited by this paper
• Regulated ATP release from astrocytes through lysosome exocytosis

  2007cited by this paper
• Dysferlin and muscle membrane repair.

  2007cited by this paper
• Lysosomes: fusion and function

  2007cited by this paper
• The Skeletal Muscle Satellite Cell: The Stem Cell That Came in From the Cold

  2006cited by this paper
• ERK2 is required for efficient terminal differentiation of skeletal myoblasts.

  2006cited by this paper
• Involvement of the tyrosine phosphatase early gene of liver regeneration (PRL–1) in cell cycle and in liver regeneration and fibrosis effect of halofuginone

  2006cited by this paper
• Inhibition of Rat Renal Fibroblast Proliferation by Halofuginone

  2006cited by this paper
• Insulin signaling diverges into Akt-dependent and -independent signals to regulate the recruitment/docking and the fusion of GLUT4 vesicles to the plasma membrane.

  2006cited by this paper
• Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane.

  2005cited by this paper
• Muscle‐fiber apoptosis in neuromuscular diseases

  2005cited by this paper
• Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.

  2004cited by this paper
• Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.

  2004cited by this paper
• The Heart in Human Dystrophinopathies

  2003cited by this paper
• Impaired membrane resealing and autoimmune myositis in synaptotagmin VII–deficient mice

  2003cited by this paper
• Actomyosin transports microtubules and microtubules control actomyosin recruitment during Xenopus oocyte wound healing.

  2003cited by this paper
• Defective membrane repair in dysferlin-deficient muscular dystrophy

  2003cited by this paper
• Repairing a torn cell surface: make way, lysosomes to the rescue.

  2002cited by this paper
• The muscular dystrophies.

  2002cited by this paper
• Role of LAMP-2 in lysosome biogenesis and autophagy.

  2002cited by this paper
• Membrane repair: Ca(2+)-elicited lysosomal exocytosis.

  2001cited by this paper
• Plasma membrane repair is mediated by Ca(2+)-regulated exocytosis of lysosomes.

  2001cited by this paper
• The earliest pathologic alterations in dysferlinopathy

  2001cited by this paper
• Dysferlinopathy (LGMD2B): a 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations.

  2001cited by this paper
• Contraction and polymerization cooperate to assemble and close actomyosin rings around Xenopus oocyte wounds

  2001cited by this paper
• Genetics of synaptic vesicle function: toward the complete functional anatomy of an organelle.

  1999cited by this paper
• Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy

  1998cited by this paper
• Halofuginone: a novel antifibrotic therapy.

  1998cited by this paper
• A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B

  1998cited by this paper
• Expression of full-length utrophin prevents muscular dystrophy in mdx mice

  1998cited by this paper
• Halofuginone: an inhibitor of collagen type I synthesis.

  1993cited by this paper
• Association of dystrophin and an integral membrane glycoprotein

  1989cited by this paper

• High‐throughput screening identifies bazedoxifene as a potential therapeutic for dysferlin‐deficient limb girdle muscular dystrophy

  2025cites this paper
• The activity of early-life gene regulatory elements is hijacked in aging through pervasive AP-1-linked chromatin opening.

  2024cites this paper
• The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments

  2024cites this paper
• Identification of bazedoxifene for the treatment of LGMD R2 by high throughput screening

  2024cites this paper
• Induction of ATF4-Regulated Atrogenes Is Uncoupled from Muscle Atrophy during Disuse in Halofuginone-Treated Mice and in Hibernating Brown Bears

  2022cites this paper
• Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy

  2021cites this paper
• Function of Drosophila Synaptotagmins in membrane trafficking at synapses

  2021cites this paper
• Lysosomes and the pathogenesis of merosin-deficient congenital muscular dystrophy.

  2021cites this paper
• Caveolae: Methods and Protocols

  2020cites this paper
• Drosophila Synaptotagmin 7 negatively regulates synaptic vesicle fusion and replenishment in a dosage-dependent manner

  2020cites this paper
• Diverse roles of Synaptotagmin-7 in regulating vesicle fusion.

  2020cites this paper
• Drosophila Synaptotagmin 7 negatively regulates synaptic vesicle release and replenishment in a dosage-dependent manner

  2020cites this paper
• Anti-carcinogenic effects of Halofuginone on lung derived cancer cells.

  2020cites this paper
• Study of Caveolae-Dependent Mechanoprotection in Human Muscle Cells Using Micropatterning and Live-Cell Microscopy.

  2020cites this paper
• Early pathological signs in young dysf−/− mice are improved by halofuginone

  2019cites this paper
• Engineered skeletal muscles for disease modeling and drug discovery.

  2019cites this paper